|
1
|
Diepgen TL and Mahler V: The epidemiology
of skin cancer. Br J Dermatol. 146 (Suppl 61):S1–S6.
2002.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lai V, Cranwell W and Sinclair R:
Epidemiology of skin cancer in the mature patient. Clin Dermatol.
36:167–176. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Pilgrim W, Hayes R, Hanson DW, Zhang B,
Boudreau B and Leonfellner S: Skin Cancer (Basal Cell Carcinoma,
Squamous Cell Carcinoma, and Malignant Melanoma): New cases,
treatment practice, and health care costs in New Brunswick, Canada,
2002-2010. J Cutan Med Surg. 18:320–331. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in china,
2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Karagas MR, Stukel TA, Greenberg ER, Baron
JA, Mott LA and Stern RS: Risk of subsequent basal cell carcinoma
and squamous cell carcinoma of the skin among patients with prior
skin cancer. Skin cancer prevention study group. JAMA.
267:3305–3310. 1992.PubMed/NCBI
|
|
7
|
Jerant AF, Johnson JT, Sheridan CD and
Caffrey TJ: Early detection and treatment of skin cancer. Am Fam
Physician. 62:357–368, 375-376, 381-382. 2000.PubMed/NCBI
|
|
8
|
Gauci J and Muscat G: A local perspective
on basal cell carcinoma: Frequency of subsequent skin tumours.
Malta Med J. 1:46–55. 2017.
|
|
9
|
Gillner J, Kirchberg K, Korge B,
Hunzelmann N, Krieg T and Scharffetter-Kochanek K: Cutaneous
metastases from a leiomyosarcoma of the testicular tunica
albuginea. Hautarzt. 51:41–45. 2000.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
10
|
Hoyt BS and Cohen PR: Cutaneous scrotal
metastasis: Origins and clinical characteristics of visceral
malignancies that metastasize to the scrotum. Int J Dermatol.
52:398–405. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bremnes RM, Veve R, Hirsch FR and Franklin
WA: The E-cadherin cell-cell adhesion complex and lung cancer
invasion, metastasis, and prognosis. Lung Cancer. 36:115–124.
2002.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhen Y, Wu C and Jiang J: Analysis of
clinicopathological features and prognostic factors in cutaneous
metastases of malignant tumors. Chin Clin Oncol. 19:152–155.
2014.
|
|
13
|
Niu JX, Meng XK and Ren JJ: Studied
microRNA gene expression in human hepatocellular carcinoma by
microRNA microarray techniques. World J Gastroenterol.
21:12605–12611. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hou X, Peng JX, Hao XY, Cai JP, Liang LJ,
Zhai JM, Zhang KS, Lai JM and Yin XY: DNA methylation profiling
identifies EYA4 gene as a prognostic molecular marker in
hepatocellular carcinoma. Ann Surg Oncol. 21:3891–3899.
2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pivarcsi A and Sonkoly E: Skin cancer
associated microRNAs. US Patent 12/994,734. Filed June 4, 2009;
issued May 5, 2011.
|
|
16
|
Glavač D and Ravnik-Glavač M: Essential
role of microRNA in skin physiology and disease. Adv Exp Med Biol.
888:307–330. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Leffell DJ: The scientific basis of skin
cancer. J Am Acad Dermatol. 42 (Suppl):S18–S22. 2000.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Thyagarajan A, Shaban A and Sahu RP:
MicroRNA-directed cancer therapies: Implications in melanoma
intervention. J Pharmacol Exp Ther. 364:1–12. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu Z, Chen D, Xu Y and Liu J: Logistic
support vector machines and their application to gene expression
data. Int J Bioinform Res Appl. 1:169–182. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yongchao GE, Sealfon SC and Speed TP:
Multiple testing and its applications to microarrays. Stat Methods
Med Res. 18:543–563. 2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Okimoto G, Zeinalzadeh A, Wenska T, Loomis
M, Nation JB, Fabre T, Tiirikainen M, Hernandez B, Chan O, Wong L
and Kwee S: Joint analysis of multiple high-dimensional data types
using sparse matrix approximations of rank-1 with applications to
ovarian and liver cancer. BioData Min. 9(24)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xiong J, Xiong K and Bing Z: Clinical and
RNA expression integrated signature for urothelial bladder cancer
prognosis. Cancer Biomark. 21:535–546. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tang RX, Chen WJ, He RQ, Zeng JH, Liang L,
Li SK, Ma J, Luo DZ and Chen G: Identification of a RNA-Seq based
prognostic signature with five lncRNAs for lung squamous cell
carcinoma. Oncotarget. 8:50761–50773. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gao X, Wu Y, Yu W and Li H: Identification
of a seven-miRNA signature as prognostic biomarker for lung
squamous cell carcinoma. Oncotarget. 7:81670–81679. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
van Malenstein H, Gevaert O, Libbrecht L,
Daemen A, Allemeersch J, Nevens F, Van Cutsem E, Cassiman D, De
Moor B, Verslype C and van Pelt J: A seven-gene set associated with
chronic hypoxia of prognostic importance in hepatocellular
carcinoma. Clin Cancer Res. 16:4278–4288. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Nakazawa H, English D, Randell PL,
Nakazawa K, Martel N, Armstrong BK and Yamasaki H: UV and skin
cancer: Specific p53 gene mutation in normal skin as a biologically
relevant exposure measurement. Proc Natl Acad Sci USA. 91:360–364.
1994.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Linck L, Liebig J, Völler D, Eichner N,
Lehmann G, Meister G and Bosserhoff A: MicroRNA-sequencing data
analyzing melanoma development and progression. Exp Mol Pathol.
105:371–379. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Goldman M, Craft B, Swatloski T, Ellrott
K, Cline M, Diekhans M, Ma S, Wilks C, Stuart J, Haussler D and Zhu
J: The UCSC Cancer Genomics Browser: Update 2013. Nucleic Acids
Res. 41 (Database Issue):D949–D954. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cline MS, Craft B, Swatloski T, Goldman M,
Ma S, Haussler D and Zhu J: Exploring TCGA Pan-Cancer Data at the
UCSC Cancer Genomics Browser. Sci Rep. 3(2652)2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Goldman M, Craft B, Swatloski T, Cline M,
Morozova O, Diekhans M, Haussler D and Zhu J: The UCSC cancer
genomics browser: Update 2015. Nucleic Acids Res. 43 (Database
Issue):D812–D817. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Turner N, Ware O and Bosenberg M: Genetics
of metastasis: Melanoma and other cancers. Clin Exp Metastasis.
35:379–391. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kong J, Zhang Y and Zhao B: A
clinicopathological analysis of 104 cases with metastatic tumors of
the skin. Chin J Diagnostic Pathol. 2:211–213. 1995.
|
|
33
|
R Core Team: R: A language and environment
for statistical computing. R Foundation for Statistical Computing,
Vienna, 2006.
|
|
34
|
Loh KC, Greenspan FS, Gee L, Miller TR and
Yeo PP: Pathological Tumor-Node-Metastasis (pTNM) staging for
papillary and follicular thyroid carcinomas: A retrospective
analysis of 700 patients. J Clin Endocrinol Metab. 82:3553–3562.
1997.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lezcano C, Shoushtari AN, Ariyan C,
Hollmann TJ and Busam KJ: Primary and metastatic melanoma with NTRK
fusions. Am J Surg Pathol. 42:1052–1058. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rhee JS, Matthews BA, Neuburg M, Logan BR,
Burzynski M and Nattinger AB: The skin cancer index: Clinical
responsiveness and predictors of quality of life. Laryngoscope.
117:399–405. 2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Morgan M, McCreedy R, Simpson J and Hay
RJ: Dermatology quality of life scales: A measure of the impact of
skin diseases. Br J Dermatol. 136:202–206. 1997.PubMed/NCBI
|
|
38
|
Rogers EM, Connolly KL, Nehal KS, Dusza
SW, Rossi AM and Lee E: Comorbidity scores associated with limited
life expectancy in the very elderly with nonmelanoma skin cancer. J
Am Acad Dermatol. 78:1119–1124. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43(e47)2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Nagy A, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep.
8(9227)2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zaorsky NG, Lee CT, Zhang E and Galloway
TJ: Skin CanceR Brachytherapy vs External beam radiation therapy
(SCRiBE) meta-analysis. Radiother Oncol. 126:386–393.
2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Riker AI, Enkemann SA, Fodstad O, Liu S,
Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, et al: The
gene expression profiles of primary and metastatic melanoma yields
a transition point of tumor progression and metastasis. BMC Med
Genomics. 1(13)2008.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lawrence MS, Stojanov P, Polak P, Kryukov
GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH,
Roberts SA, et al: Mutational heterogeneity in cancer and the
search for new cancer-associated genes. Nature. 499:214–218.
2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wiltgen M, Gerger A and Smolle J: Tissue
counter analysis of benign common nevi and malignant melanoma. Int
J Med Inform. 69:17–28. 2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Esteva A, Kuprel B, Novoa RA, Ko J,
Swetter SM, Blau HM and Thrun S: Dermatologist-level classification
of skin cancer with deep neural networks. Nature. 542:115–118.
2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Esteva A, Kuprel B, Novoa RA, Ko J,
Swetter SM, Blau HM and Thrun S: Corrigendum: Dermatologist-level
classification of skin cancer with deep neural networks. Nature.
546(686)2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Masood A and Al-Jumaily AA: Computer aided
diagnostic support system for skin cancer: A review of techniques
and algorithms. Int J Biomed Imaging. 2013(323268)2013.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Chang P, Bing Z, Tian J, Zhang J, Li X, Ge
L, Ling J, Yang K and Li Y: Comprehensive assessment gene
signatures for clear cell renal cell carcinoma prognosis. Medicine
(Baltimore). 97(e12679)2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000.PubMed/NCBI View Article : Google Scholar
|
|
51
|
The Gene Ontology Consortium. The Gene
Ontology Resource: 20 years and still GOing strong. Nucleic Acids
Res. 47:D330–D338. 2019.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613.
2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Panno ML, Giordano F, Mastroianni F,
Morelli C, Brunelli E, Palma MG, Pellegrino M, Aquila S, Miglietta
A, Mauro L, et al: Evidence that low doses of Taxol enhance the
functional transactivatory properties of p53 on p21 waf promoter in
MCF-7 breast cancer cells. FEBS Lett. 580:2371–2380.
2006.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Palazzo E, Kellett MD, Cataisson C, Bible
PW, Bhattacharya S, Sun HW, Gormley AC, Yuspa SH and Morasso MI: A
novel DLX3-PKC integrated signaling network drives keratinocyte
differentiation. Cell Death Differ. 24:717–730. 2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Jiang L, Campagne C, Sundström E, Sousa P,
Imran S, Seltenhammer M, Pielberg G, Olsson MJ, Egidy G, Andersson
L and Golovko A: Constitutive activation of the ERK pathway in
melanoma and skin melanocytes in Grey horses. BMC Cancer.
14(857)2014.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Palazzo E, Kellett M, Cataisson C, Gormley
A, Bible PW, Pietroni V, Radoja N, Hwang J, Blumenberg M, Yuspa SH
and Morasso MI: The homeoprotein DLX3 and tumor suppressor p53
co-regulate cell cycle progression and squamous tumor growth.
Oncogene. 35:3114–3124. 2016.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Ito K, Park SH, Nayak A, Byerly JH and
Irie HY: PTK6 Inhibition suppresses metastases of triple-negative
breast cancer via SNAIL-dependent E-cadherin regulation. Cancer
Res. 76:4406–4417. 2016.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Rivenbark AG, Livasy CA, Boyd CE, Keppler
D and Coleman WB: Methylation-dependent silencing of CST6 in
primary human breast tumors and metastatic lesions. Exp Mol Pathol.
83:188–197. 2007.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Soares AS, Costa VM, Diniz C and Fresco P:
Inosine strongly enhances proliferation of human C32 melanoma cells
through PLC-PKC-MEK1/2-ERK1/2 and PI3K pathways. Basic Clin
Pharmacol Toxicol. 116:25–36. 2015.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Le NA, Katsuyama M, Demura M, Tanii H,
Katsuyama H and Saijoh K: Regulation of serine protease inhibitor
Kazal type-5 (SPINK5) gene expression in the keratinocytes. Environ
Health Prev Med. 19:307–313. 2014.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Frommherz L, Küsel J, Zimmer A, Fischer J
and Has C: Skin fragility caused by biallelic KRT10 mutations: An
intriguing form of self-improving epidermolytic ichthyosis. Br J
Dermatol. 182:780–785. 2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Shen K, Yu W, Yu Y, Liu X and Cui X:
Knockdown of TMEM45B inhibits cell proliferation and invasion in
gastric cancer. Biomed Pharmacother. 104:576–581. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Canbay E, Eraltan IY, Cercel A, Isbir T,
Gazioglu E, Aydogan F, Cacina C, Cengiz A, Ferahman M, Zengin E and
Unal H: CCND1 and CDKN1B polymorphisms and risk of breast cancer.
Anticancer Res. 30:3093–3098. 2010.PubMed/NCBI
|
|
64
|
Fan H, Lv P, Mu T, Zhao X, Liu Y, Feng Y,
Lv J, Liu M and Tang H: LncRNA n335586/miR-924/CKMT1A axis
contributes to cell migration and invasion in hepatocellular
carcinoma cells. Cancer Lett. 429:89–99. 2018.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Wang W, Chu HJ, Liang YC, Huang JM, Shang
CL, Tan H, Liu D, Zhao YH, Liu TY and Yao SZ: FABP5 correlates with
poor prognosis and promotes tumor cell growth and metastasis in
cervical cancer. Tumor Biol. 37:14873–14883. 2016.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Chae YS, Kim JG, Kang BW, Lee SJ, Jeon HS,
Park JS, Choi GS and Lee WK: PPP1R13Lvariant associated with
prognosis for patients with rectal cancer. J Cancer Res Clin Oncol.
139:465–473. 2013.PubMed/NCBI View Article : Google Scholar
|
